Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease

Abstract

The aim of this study was to analyze the efficacy of a cognitive training program on cognitive performance and quality of life in nondemented Parkinson's disease patients. Participants who met UK Brain Bank diagnosis criteria for Parkinson's disease, with I-III Hoehn & Yahr, aged 50-80, and nondemented (Mini-Mental State Examination ≥ 23) were recruited. Patient's cognitive performance and functional and quality-of-life measures were assessed with standardized neuropsychological tests and scales at baseline and after 4 weeks. Subjects were randomly and blindly allocated by age and premorbid intelligence (Vocabulary, Wechsler Adult Intelligence Scale-III) into 2 groups: an experimental group and a control group. The experimental group received 4 weeks of 3 weekly 45-minute sessions using multimedia software and paper-and-pencil cognitive exercises, and the control group received speech therapy. A total of 28 patients were analyzed. Compared with the control group participants (n = 12), the experimental group participants (n = 16) demonstrated improved performance in tests of attention, information processing speed, memory, visuospatial and visuoconstructive abilities, semantic verbal fluency, and executive functions. There were no observable benefits in self-reported quality of life or cognitive difficulties in activities of daily living. We concluded that intensive cognitive training may be a useful tool in the management of cognitive functions in Parkinson's disease. © 2011 Movement Disorder Society.

Mild Cognitive Impairment and Parkinson’s Disease - Something to Remember

“…In the case of the patients with more prominent executive deficits, there has been interest in agents that may have an alerting capacity such as modafanil, [40] as well as drugs targeting the noradrenergic system such as atomoxetine [33]. Another therapeutic strategy which is gaining an evidence base for early cognitive deficits in PD is cognitive training, [41,42] although it remains to be seen whether demonstrated improvements on neuropsychological tests translate into real-world improvements in cognitive function.…”

A pilot study on the benefit of cognitive rehabilitation in Parkinson’s disease

“…Certainly, there is already evidence in favor of computerized cognitive training in healthy subjects by demonstrating improvements in working memory and changes in brain biochemistry concerning the density of cortical dopamine D1 receptors [McNab et al 2009]. Some research on cognitive rehabilitation in patients with PD revealed promising results in terms of supporting mental activity [Cerasa et al 2014;Petrelli et al 2014;Zimmermann et al 2014;Reuter et al 2012;París et al 2011;Sammer et al 2006]. Thus, drug therapy combined with computerized cognitive training might achieve a more favorable benefit when compared with pharmacotherapy alone [Brusa et al 2013].…”

Approaches to Cognitive Stimulation in the Prevention of Dementia

“…They can affect how people are able to interact with technological devices and training materials. However, despite these deficits, computerized cognitive training has been shown to be feasible and effective in various pathological conditions such as Parkinson's disease [87] and stroke [88]. Computerized interventions and tests might actually offer optimized and adjustable interfaces to overcome some of these deficits, e.g.…”